2 cheap UK shares under £5 to buy right now!

I’m searching for the best cheap UK shares to buy for my portfolio. One of them is a big-dividend-paying FTSE 100 hero. Here’s why I’d buy it today.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

I don’t think share investors like myself necessarily need to spend a fortune to build a brilliant stocks portfolio. Here are two top-quality UK shares (including one from the FTSE 100) I think could help me make a lot of money. Both change hands for less than £5 each.

A cheap UK medical share

I think spending on some choice healthcare shares could be a good idea. Many medical companies have suffered a torrid time over the past year as the pandemic has shattered the number of elective surgical procedures being carried out.

However, I think the long-term outlook for the sector remains extremely bright. In particular, soaring healthcare spending in developing markets provides plenty of opportunities for businesses.

Advanced Medical Solutions Group (LSE: AMS) is a cheap UK share I’m expecting to thrive. This company manufactures a range of wound treatment products that help repair, manage and close up damaged and cut tissue during and after surgery.

Its highly-developed technologies have made it one of the largest operators on the planet. Pleasingly, AMS has plenty of capital with which to continue developing cutting-edge treatments too.

It had more than £61m worth of cash on the balance sheet as of June, thanks to rebounding end markets in the first half of 2021. I’d buy this share despite the possibility that a surge in Covid-19 cases could put an end to its recent rebound. Revenues here jumped 28% year-on-year in the first half.

A FTSE 100 growth and dividend share

The FTSE 100 is packed with top-quality, low-cost shares for me to buy as well. One that’s attracting me with its exceptional value today is banking colossus HSBC Holdings (LSE: HSBA). This blue-chip stock trades on an ultra-low forward price-to-earnings (P/E) ratio of 9.4 times. It also carries an index-beating 4.8% dividend yield.

I think HSBC’s a great buy because of its focus on fast-growing Asian markets. In the short term, this could prove problematic as the recovery from Covid-19 is tipped to be slower in emerging regions like this. But, over a longer-term time horizon, I think this could pay off handsomely.

Economic growth in Asia is tipped to remain much stronger than in developed countries in the post-pandemic environment. This, allied with the low penetration of banking in many of the places where HSBC operates, could help deliver some monumental returns.

Analysts at McKinsey Company think total banking revenue pools in the region will grow between 7% and 8% per year over the next five years.

Sure, HSBC faces intense competition from smaller, more agile digital-led challenger banks in Asia. However, the bank has one of the industry’s most trusted brands.That’s something I feel could give it an edge against these new kids on the block.

The business is also investing heavily in its own digital operations. I think this could also could help me make a lot of cash over the next 10 years.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended Advanced Medical Solutions and HSBC Holdings. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »